Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...
Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...
Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback